Milan Criteria for Liver Transplantation
Assess suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma, recommended by AASLD guidelines .
49 entries · Page 2 of 2
Assess suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma, recommended by AASLD guidelines .
Provides improved cancer prognosis over the original score , based on serum biomarkers.
Measures treatment response, specifically to cytotoxic drugs, based on tumor shrinkage.
Predicts 30-day readmission risk in patients with cirrhosis.
Diagnoses steatohepatitis, based on histology, in NAFLD patients.
Estimates amount of scarring in the liver based on several laboratory tests.
Calculates the pediatric version of the MELD score for liver cirrhosis severity and transplant planning.
Reference values for normal portal vein diameter on ultrasound across all age groups, from neonates to adults, with clinical significance.
Normal portal vein velocity on Doppler ultrasound ranges from 20–30 cm/s, a key metric for detecting portal hypertension and hepatic vascular disease.
Differentiates cholestatic from hepatocellular liver injury, recommended by ACG guidelines .
Estimates mortality of patients with pancreatitis, based on initial and 48-hour lab values.
Estimates risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B.
Estimates survival from primary sclerosing cholangitis.
Revised version of the original scoring system for the diagnosis of autoimmune hepatitis.
Defines presence of portal hypertension in patients with ascites.
Provides diagnostic criteria and severity grading for acute cholangitis.
Predicts mortality in end-stage liver disease patients for transplant planning (UK-specific).
No entries match your filter.